Key takeaways:
Some common blood tests — like a complete blood count (CBC), calcium level, and kidney function tests — can help screen for multiple myeloma. These tests can’t diagnose multiple myeloma though.
For diagnosis, you’ll need specialized blood tests that measure antibody levels and detect abnormal proteins in the blood.
Many people also need urine tests, imaging studies, and/or bone marrow biopsies to confirm that they have multiple myeloma.
Multiple myeloma is a rare cancer of the plasma cells in bone marrow. Plasma cells are a type of infection-fighting cell. Multiple myeloma develops when plasma cells grow uncontrolled and produce large amounts of abnormal proteins.
Over time, cancerous plasma cells start to “crowd out” healthy cells in the bone marrow. This means there’s less room for blood cells to form. And this leads to symptoms like anemia and frequent infections.
Blood tests can help diagnose multiple myeloma. Common blood tests can help identify whether or not a person needs further testing to see if they have multiple myeloma.
Need help reading your blood test results? Check out our guide to common blood tests.
It’s hard to spot multiple myeloma. Here are six early signs of multiple myeloma to watch for.
What’s it like to live with multiple myeloma? One man shares his inspiring, decades-long journey.
Specialized blood tests and other medical tests can confirm whether someone has multiple myeloma.
Here, we’ll take a look at which common blood tests can show signs of multiple myeloma. And we’ll also cover which specialized blood tests can confirm a diagnosis.
A complete blood count (CBC) measures different types of cells in the blood, including white blood cells, red blood cells, and platelets. People with multiple myeloma often have low levels of some or all of these types of cells.
A CBC can’t diagnose multiple myeloma. But it can help identify people who need specialized testing to see if they have multiple myeloma or another condition.
Calcium is a mineral stored in the bones. People with multiple myeloma develop bone breakdown as the cancerous cells damage bone marrow and surrounding bone tissue. When bone breaks down, it releases calcium into the bloodstream. People with multiple myeloma will have high levels of calcium in the blood. This is called hypercalcemia.
Not everyone with hypercalcemia has multiple myeloma. But a high calcium level is a sign that people should be checked for multiple myeloma and other medical conditions.
Kidney function tests give a picture of the kidneys’ overall health. A creatinine level is part of a kidney function test.
In multiple myeloma, the abnormal proteins created by the cancer cells are released into the blood and then travel to the kidney. These proteins can damage the kidneys. That damage can show up as a high creatinine level.
Again, not everyone with a high creatinine level will have multiple myeloma. But a high creatinine level is a sign that you need to be checked for medical conditions that can damage the kidneys.
Damaged tissue releases an enzyme into the bloodstream called lactate dehydrogenase (LDH), also called lactic acid dehydrogenase. People with tissue injury caused by multiple myeloma may have high levels of LDH.
Not everyone with a high LDH level has multiple myeloma. But a high level can raise concern for multiple myeloma. This is especially true if people also have other concerning blood test results, like high calcium levels and unusual CBC results.
Immunoglobulins are a type of protein made by plasma cells. A quantitative immunoglobulin test shows how much of each type of immunoglobulin is in the blood.
Cancerous plasma cells overproduce certain immunoglobulins. People with multiple myeloma often have unusual or unbalanced patterns in their quantitative immunoglobulin levels. For example, one immunoglobulin level may be much higher than the others.
A quantitative immunoglobulin test can’t diagnose multiple myeloma on its own. But there are fewer medical conditions that cause an abnormal result. That means there’s a higher chance that multiple myeloma is causing the changes — especially if you also have other abnormal test results.
Serum protein electrophoresis (SPEP) separates immunoglobulins in the blood based on their size and electrical charge. People with multiple myeloma are more likely to have the SPEP showing a high level of an abnormal immunoglobulin called a monoclonal protein. Monoclonal protein is also called “M protein.” And the high level is sometimes referred to as an “M spike.”
An M spike may not be enough to diagnose multiple myeloma. But finding a high level of monoclonal protein is the first step to confirming a diagnosis. More specialized tests can figure out exactly what type of monoclonal protein is being overproduced. This is important for diagnosis and treatment.
Serum free light chain assay (sFLC assay) is a blood test that measures light chain proteins. Light chain proteins are made by plasma cells. Normally, there should be a balance between light and heavy chains in the body. But cancerous plasma cells make more light protein, throwing off the balance in the body.
An abnormal result can be a sign of multiple myeloma. It’s especially helpful if someone doesn’t have an M spike — but has other blood test results that suggest multiple myeloma.
Beta-2 microglobulin is a tumor maker. The presence of a tumor marker usually indicates that cancer is present somewhere in the body. Beta-2 microglobulin is a tumor marker that accumulates in people who have multiple myeloma and other bone marrow disorders. The presence of beta-2 microglobulin is a sign of multiple myeloma.
Blood tests alone may not be enough to diagnose multiple myeloma. Other tests you may need to diagnose multiple myeloma include:
Urine tests: The abnormal proteins made by cancerous plasma cells can spill in the urine. Urine tests like urine protein electrophoresis (UPEP) measure these protein levels and can help diagnose multiple myeloma.
Imaging tests: Your healthcare team may ask you to get an imaging test to look for lesions in the bones caused by multiple myeloma. Common imaging tests for multiple myeloma include whole-body CT scans, MRIs, and PET scans.
Bone marrow biopsy: During a bone marrow biopsy, a sample of the tissue inside the bone is removed for analysis. This test allows the healthcare team to confirm that cancer cells are present in the bone marrow.
Multiple myeloma is a cancer of plasma cells. There’s no one test that diagnoses multiple myeloma. Blood tests can help diagnose multiple myeloma by signs of multiple myeloma. But usually people need several types of blood tests to confirm the presence of multiple myeloma. Some people also need urine tests, imaging tests, and a bone marrow biopsy to confirm a diagnosis of multiple myeloma.
American Cancer Society. (n.d.). Tests for multiple myeloma.
Health Encyclopedia. (n.d.). Protein electrophoresis (blood). University of Rochester Medical Center.
MedlinePlus. (2022). Beta 2 Microglobulin (B2M) tumor marker test.
MedlinePlus. (2022). PET scan.
MedlinePlus. (2023). Lactate Dehydrogenase (LDH) test.
MedlinePlus. (2024). Calcium blood test.
MedlinePlus. (2024). Free light chains.
MedlinePlus. (2024). Urine protein electrophoresis test.
National Cancer Institute. (n.d.). Cancer stat facts: Myeloma. National Institute of Health.
Oyajobi, B. O. (2007). Multiple myeloma/hypercalcemia. Arthritis Research and Therapy.
Terpos, E., et al. (2016). The role of imaging in the treatment of patients with multiple myeloma in 2016. American Society of Clinical Oncology Educational Book.
Tosi, P., et al. (2013). Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions. Therapeutic Advances in Hematology.